Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohort
on behalf of the SURDIAGENE Study group, Barnabas Gellen, Nathalie Thorin‐Trescases, Éric Thorin, Elise Gand, P. Sosner, Sonia Brishoual, Vincent Rigalleau, David Montaigne, Vincent Javaugue, Yann Pucheu, Philippe Gatault, X. Piguel, Samy Hadjadj, Pierre‐Jean Saulnier
Topics & Concepts
MaceMedicineInternal medicineHazard ratioType 2 diabetesProspective cohort studyMyocardial infarctionProportional hazards modelDiabetes mellitusCohortCause of deathEndocrinologyDiseaseConfidence intervalPercutaneous coronary interventionCell Adhesion Molecules ResearchAdipokines, Inflammation, and Metabolic DiseasesSepsis Diagnosis and Treatment